Physician profile
David M Somers
NPI 1760644249
$5,442.51
in general payments reported to CMS, 2019-2025
33 companies · $2,108 in 2025
The $2,108 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $113 · 2021: $172 · 2022: $278 · 2023: $1,826 · 2024: $609 · 2025: $2,108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,313 · Food and Beverage: $2,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,313.38 |
| Food and Beverage | $2,228.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,603.79 | 2025 | |
| Paragon 28, INC. | $1,333.38 | 2023 | Portfolio, Mtp |
| Organogenesis INC. | $483.53 | 2019-2025 | Affinity, Apligraf, Puraply |
| Paratek Pharmaceuticals, INC. | $268.90 | 2022-2025 | Nuzyra |
| Epsfl, LLC | $252.00 | 2023 | |
| Smith+Nephew, INC. | $246.09 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix |
| Kerecis Limited | $152.82 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Osiris Therapeutics INC. | $113.50 | 2019 | |
| Amgen INC. | $110.42 | 2024 | Krystexxa |
| Bone Support INC. | $101.18 | 2024 | Ceramentbone Void Filler, Cerament G |
| Globus Medical, INC. | $87.11 | 2025 | Senza |
| Bioventus LLC | $82.08 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Boston Scientific Corporation | $69.27 | 2023-2024 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Nevro Corp. | $68.37 | 2023-2024 | Senza |
| Convatec INC. | $53.54 | 2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $47.89 | 2022 | |
| Stryker Corporation | $42.10 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.39 | 2021-2023 | Jublia |
| Abbvie INC. | $33.35 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $33.26 | 2025 | Purified Cortrophin Gel |
| Dynasplint Systems INC. | $22.89 | 2024 | Dynasplint |
| Acera Surgical, INC. | $22.19 | 2025 | Restrata Wound Matrix |
| Grt US Holding, INC. | $21.87 | 2022 | |
| Sandoz INC. | $21.11 | 2019 | |
| Medtronic, INC. | $20.50 | 2024 | Intellis Adaptivestim |
| Zimmer Biomet Holdings, INC. | $17.03 | 2022 | |
| Heron Therapeutics, INC. | $16.50 | 2021 | |
| Fidia Pharma USA INC. | $16.20 | 2019 | |
| Innovation Technologies INC | $14.92 | 2025 | Irrisept |
| Zimvie INC. | $14.22 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $11.57 | 2019 | |
| Novum Pharma, LLC | $11.55 | 2019 | |
| Aroa Biosurgery Incorporated | $9.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Somers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.